These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6220469)

  • 1. Lymphoid cell-glioma cell interaction enhances cell coat production by human gliomas: novel suppressor mechanism.
    Dick SJ; Macchi B; Papazoglou S; Oldfield EH; Kornblith PL; Smith BH; Gately MK
    Science; 1983 May; 220(4598):739-42. PubMed ID: 6220469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack.
    Gately CL; Muul LM; Greenwood MA; Papazoglou S; Dick SJ; Kornblith PL; Smith BH; Gately MK
    J Immunol; 1984 Dec; 133(6):3387-95. PubMed ID: 6238097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms by which human gliomas may escape cellular immune attack.
    Gately MK; Glaser M; McCarron RM; Dick SJ; Dick MD; Mettetal RW; Kornblith PL
    Acta Neurochir (Wien); 1982; 64(3-4):175-97. PubMed ID: 6215833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.
    Gately MK; Glaser M; Dick SJ; Mettetal RW; Kornblith PL
    J Natl Cancer Inst; 1982 Dec; 69(6):1245-54. PubMed ID: 6183477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural features of the lymphocyte-stimulated halos produced by human glioma-derived cells in vitro.
    Oberc-Greenwood MA; Muul LM; Gately MK; Kornblith PL; Smith BH
    J Neurooncol; 1986; 3(4):387-96. PubMed ID: 2420943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lymphocyte-specific chemokines in human malignant glioma: Essential role of LARC in cellular immunity of malignant glioma.
    Kimura T; Takeshima H; Nomiyama N; Nishi T; Kino T; Kochi M; Kuratsu JI; Ushio Y
    Int J Oncol; 2002 Oct; 21(4):707-15. PubMed ID: 12239608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.
    Baltuch GH; Villemure JG; McCrea E; Antel JP
    Neurosurgery; 1994 Sep; 35(3):450-6; discussion 456. PubMed ID: 7800136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas.
    Kuppner MC; Hamou MF; de Tribolet N
    Cancer Res; 1988 Dec; 48(23):6926-32. PubMed ID: 3052809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF-15 contributes to proliferation and immune escape of malignant gliomas.
    Roth P; Junker M; Tritschler I; Mittelbronn M; Dombrowski Y; Breit SN; Tabatabai G; Wick W; Weller M; Wischhusen J
    Clin Cancer Res; 2010 Aug; 16(15):3851-9. PubMed ID: 20534737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro resistance of cloned human glioma cells to natural killer activity of allogeneic peripheral lymphocytes.
    Zänker KS; Trappe A; Blümel G
    Br J Cancer; 1982 Oct; 46(4):617-24. PubMed ID: 7138767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2.
    Sawamura Y; Hosokawa M; Kuppner MC; Kobayashi H; Aida T; Abe H; de Tribolet N
    Cancer Res; 1989 Apr; 49(7):1843-9. PubMed ID: 2784352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology of interleukin-2-stimulated human peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitro.
    Hook GR; Greenwood MA; Barba D; Ikejiri B; Chen SN; Oldfield EH; Weber RJ; Muul LM
    J Natl Cancer Inst; 1988 Apr; 80(3):171-7. PubMed ID: 3258038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-mediated cytotoxicity against gliomas.
    Rainbird S; Allwood G; Ridley A
    Brain; 1981 Sep; 104(3):451-64. PubMed ID: 7272710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions.
    Ishikawa E; Tsuboi K; Saijo K; Takano S; Ohno T
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1505-12. PubMed ID: 15275738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
    J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of interleukin-2 in immune surveillance against brain tumors.
    Yoshida S; Takai N; Tanaka R
    Neurosurgery; 1987 Nov; 21(5):627-30. PubMed ID: 3501073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes.
    Hoa N; Ge L; Kuznetsov Y; McPherson A; Cornforth AN; Pham JT; Myers MP; Ahmed N; Salsman VS; Lamb LS; Bowersock JE; Hu Y; Zhou YH; Jadus MR
    J Immunol; 2010 Oct; 185(8):4793-803. PubMed ID: 20855883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of experimental brain tumors (review).
    Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
    Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo.
    Glick RP; Lichtor T; Kim TS; Ilangovan S; Cohen EP
    Neurosurgery; 1995 Mar; 36(3):548-55. PubMed ID: 7753355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.